GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer

Published:2009-03-10 Issue:3 Volume:9 Page:202-207
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Alakus H,Warnecke-Eberz U,Bollschweiler E,Mönig S P,Vallböhmer D,Brabender J,Drebber U,Baldus S E,Riemann K,Siffert W,Hölscher A H,Metzger R

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj20095.pdf

Reference46 articles.

1. Pisani P, Parkin DM, Ferlay J . Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993; 55: 891–903.

2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ . Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.

3. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH . Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549–555.

4. Devesa SS, Blot WJ, Fraumeni Jr JF . Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049–2053.

5. Sherman CA, Turrisi AT, Wallace MB, Reed CE . Locally advanced esophageal cancer. Curr Treat Options Oncol 2002; 3: 475–485.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma;PLOS ONE;2022-11-03

2. CC Genotype of GNAS c.393C>T (rs7121) Polymorphism Has a Protective Effect against Development of BK Viremia and BKV-Associated Nephropathy after Renal Transplant;Pathogens;2022-10-01

3. Biomarkers for the prediction of esophageal cancer neoadjuvant chemoradiotherapy response: A systemic review;Critical Reviews in Oncology/Hematology;2021-11

4. Personalized Medicine Through GPCR Pharmacogenomics;Reference Module in Biomedical Sciences;2021

5. Pharmacogenomic Characterization in Bipolar Spectrum Disorders;Pharmaceutics;2019-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3